A patient who died when a Zoll LifeVest failed to work has led the manufacturer Zoll Medical and the FDA to issue a safety alert for physicians and patients using the wearable heart monitor and ...
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced that a study demonstrating a reduction in ...
A phase 3 trial of Zoll Medical’s LifeVest has missed its primary endpoint. The study found that people who started using the wearable defibrillator the week after they had a heart attack were as ...
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that the Centers for Medicare and ...
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that physicians at all of the 17 “Honor Roll” hospitals and all of the 50 “Best Cardiology ...
ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT CHELMSFORD, ...
Zoll Medical Corporation and Lifecor Inc have reached an exclusive distribution agreement for sales of the Lifecor LifeVest System to hospitals for inpatient use in the United States and Canada ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback